Additionally, the percentage of patients with elevated serum CEA (9.0 versus 0.8 per cent, P<0.001) and CA19-9 (56.2 versus 5.5 per cent, P<0.001) levels was higher in the cancer group than in the control group. Here, CEACAM5 is linked to cancer.